Author

E. Krug

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:DNA methylation· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

C. R. Zhang· 1 shared D. A. Fisher· 1 shared G. A. Challen· 1 shared G. Virdi· 1 shared H. Bjeije· 1 shared H. Celik· 1 shared H. K. Koblish· 1 shared J. Fowles· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. R. Zhang

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms

H. Celik, E. Krug, C. R. Zhang, W. Han, N. Issa, W. K. Koh, H. Bjeije, O. Kukhar, M. Allen, T. Li, D. A. Fisher, J. Fowles, T. N. Wong, M. C. Stubbs, H. K. Koblish, , G. A. Challen

This paper introduces a humanized animal model using patient-derived xenografts to study myeloproliferative neoplasms and identify therapeutic vulnerabilities.

bioRxiv · Nov 12, 2020Cancer Biology

Chemerin increases T-cell mediated cytotoxicity of human tumors via modulation of a novel CMKLR1/PTEN/PD-L1 axis

K. Rennier, E. Krug, G. Virdi, W. J. Shin, R. Pachynski

This study shows chemerin enhances T-cell cytotoxicity against tumors by modulating the CMKLR1/PTEN/PD-L1 axis, with effects comparable to PD-L1 inhibition.

bioRxiv · Sep 30, 2019 · PreprintCancer Biology